NCT00429793 · Interventional trial
Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Overall registry status Completed
Phase 2
Conditions Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
Delaware Valley sites
- Gynecologic Oncology Group · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory